Department of Cellular Immunology, Max-Planck-Institute for Immunobiology, Freiburg, Germany.
PLoS Negl Trop Dis. 2009 Jul 14;3(7):e480. doi: 10.1371/journal.pntd.0000480.
The balance between T helper (Th) 1 and Th2 cell responses is a major determinant of the outcome of experimental leishmaniasis, but polarized Th1 or Th2 responses are not sufficient to account for healing or nonhealing. Here we show that high arginase activity, a hallmark of nonhealing disease, is primarily expressed locally at the site of pathology. The high arginase activity causes local depletion of L-arginine, which impairs the capacity of T cells in the lesion to proliferate and to produce interferon-gamma, while T cells in the local draining lymph nodes respond normally. Healing, induced by chemotherapy, resulted in control of arginase activity and reversal of local immunosuppression. Moreover, competitive inhibition of arginase as well as supplementation with L-arginine restored T cell effector functions and reduced pathology and parasite growth at the site of lesions. These results demonstrate that in nonhealing leishmaniasis, arginase-induced L-arginine depletion results in impaired T cell responses. Our results identify a novel mechanism in leishmaniasis that contributes to the failure to heal persistent lesions and suggest new approaches to therapy.
辅助性 T 细胞(Th)1 和 Th2 细胞反应之间的平衡是实验性利什曼病结局的主要决定因素,但极化的 Th1 或 Th2 反应不足以解释愈合或不愈合的原因。在这里,我们发现高水平的精氨酸酶活性(非愈合疾病的标志)主要在病变部位局部表达。高水平的精氨酸酶活性导致局部精氨酸耗竭,从而损害病变部位 T 细胞的增殖和产生干扰素-γ的能力,而局部引流淋巴结中的 T 细胞则正常反应。通过化疗诱导的愈合导致精氨酸酶活性得到控制,并逆转局部免疫抑制。此外,精氨酸酶的竞争抑制以及补充精氨酸恢复了 T 细胞效应功能,并减少了病变部位的病理和寄生虫生长。这些结果表明,在非愈合性利什曼病中,精氨酸酶诱导的精氨酸耗竭导致 T 细胞反应受损。我们的研究结果确定了利什曼病中一种新的机制,该机制导致持续病变无法愈合,并为治疗提供了新的方法。